U.S. Population Health Management Market Leading Players Analysis, And Growth Factors By 2030

U.S. Population Health Management Industry Overview

The U.S. population health management market size was valued at USD 20.6 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 19.5% from 2022 to 2030.

The market is majorly driven by the growing demand for healthcare IT services and solutions that support value-based healthcare delivery, resulting in a transition from Fee-For-Service (FFS) to a Value-Based Payment (VBP) model.

Increasing healthcare expenditure and the rising need for value-based healthcare and effective disease management across different care settings are expected to drive the market in the U.S. More than 130 million people in the U.S. suffer from at least one chronic condition. Chronic conditions are responsible for around 70% of deaths in the U.S. each year, resulting in 1.7 million deaths.

Gather more insights about the market drivers, restrains and growth of the U.S. Population Health Management Market

Managing comorbidities is challenging due to the large target population in the region. Implementation of PHM can help in the identification of unwell patients and improve disease prevention and management, leading to financial savings. To encourage the adoption of PHM systems, the Centers for Medicare & Medicaid Services (CMS) has introduced the Value-Based Payment Modifier. It provides differential payment to a group of physicians based upon the quality of care provided as opposed to the cost of care during their performance period.

Population health management solutions based on open Application Programming Interfaces (APIs) are helpful for the management of chronic conditions with high treatment costs, such as cardiac diseases, asthma, and diabetes. PHM solutions also help reduce the cost of care, improve patient outcomes. PHM software also enables better analysis of patient data to make informed decisions.

In the U.S., providers, payers, providers-payers, and accountable care organizations are the promoters of PHM systems. Many providers and payers require upgrading and automating their healthcare management systems, which can improve healthcare delivery and help departments, collaborate with each other. The providers mainly focus on chronic diseases, such as diabetes and cardiovascular disorders that are generally responsible for significant healthcare costs. The rising prevalence of lifestyle disorders has increased the need for effective management of the disease burden on healthcare centers.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• Connected Drug Delivery Devices Market - The global connected drug delivery devices market size was estimated at USD 4.84 billion in 2022 and is expected to grow at a lucrative compound annual growth rate (CAGR) of 23.4% during the forecast period.
• Clinical Trial Management Services Market - The global clinical trial management services market was valued at USD 27.1 billion in 2021. It is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030.

Market Share Insights

• May 2020: Medecision announced a few important enhancements to its Aerial Platform, to enable customers to support vulnerable patients and members during the COVID-19 crisis.

Key Companies profiled:

Some prominent players in the U.S. population health management market include

• Allscripts Healthcare
• Cerner Corp.
• Conifer Health Solutions, LLC
• EClinicalWorks
• Enli Health Intelligence
• McKesson Corp.
• Medecision
• Optum, Inc.
• Advisory Board
• Koninklijke Philips N.V.
• Athenahealth, Inc.
• RedBrick Health
• Welltok

Order a free sample PDF of the U.S. Population Health Management Market Intelligence Study, published by Grand View Research.